Salt Lake City, UT - Prolatis’ announced August 13 that it will conduct a voluntary nationwide recall of all its sold under the name Prolatis’ prior to August 9, 2010. FDA lab analysis found that the male enhancement drugs contain Sulfoaildenafil, an FDA-approved drug used to treat male erectile dysfunction. The labels on Prolatis’ do not list that ingredient, making Prolatis’ unapproved by the FDA.